Controversies about augmentation therapy in α1-antitrypsin deficiency (AATD) still exist. Owing to the low prevalence of AATD and variability in its natural history, augmentation must be personalised in reference centres after careful consideration of pros and cons with the patient.
Read the pick of the week | Submit your manuscript to the European Respiratory Review
Friday, 5 January 2024
European Respiratory Review: pick of the week
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment